Hi mooers!
$Palantir (PLTR.US)$ is releasing its Q3 earnings on November 4 after the bell. Unlock insights with PLTR Earnings Hub>>
$Palantir (PLTR.US)$ recently joined the S&P 500 index. The company has been riding the AI and big data wave recently, and gained +140% increase on its share price. PLTR's current market cap is standing near $100 billion.
What will the company's future performance look like? Subscribe to @Moo Live...

Hi mooers!
$American Airlines (AAL.US)$ is releasing its Q3 earnings on October 24 before the bell. Unlock insights with AAL Earnings Hub>>
With recent oil price falling and air-travel demand recovery going on, airline stocks are attracting market's attention. As of October 21, $Delta Air Lines (DAL.US)$'s stock price has gone up 9% since its Q3 earnings release, $United Airlines (UAL.US)$ stock has surged 15% since its Q3 earnin...

$Kintara Therapeutics (KTRA.US)$ this is the fastest cvr issuance since my experience in biotech companies merger. As they stated it will be 5.45% of the current OS of 53m+ as stated in their 8k filling.

$Momentus (MNTS.US)$ Bounced off 1.04 again! Break that dont just tease it! Hehehe

$Momentus (MNTS.US)$ .7363 broke

$Kintara Therapeutics (KTRA.US)$ 15mins to meeting time!

$LumiraDx (LMDXF.US)$
**Image Description:**
The image appears to be a portion of a legal document, specifically a **Competition and Markets Authority (CMA)** report. The text discusses the **merger of LumiraDx and Roche**, focusing on whether the merger was necessary to prevent LumiraDx's exit from the UK market.
Key points include:
* Third parties acknowledged LumiraDx's technology as highly regarded.
* COVID-19 negatively impacted LumiraDx's financial position.
* Alternative funding options...